Paul Tudor Jones's AVXL Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 42,708 shares of Anavex Life Sciences Corp. (AVXL) worth $131,114, representing 0.00% of the portfolio. First purchased in 2016-Q3, this medium-term investment has been held for 9 quarters.
Based on 13F filings, Paul Tudor Jones has maintained a strategic position in AVXL, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 46,044 shares. Largest reduction occurred in Q1 2025, reducing 46,044 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Anavex Life Sciences (AVXL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Anavex Life Sciences (AVXL) Trades by Paul Tudor Jones
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +42,708 | New Buy | 42,708 | $3.07 |
| Q1 2025 | -46,044 | Sold Out | 0 | $0.00 |
| Q4 2024 | +46,044 | New Buy | 46,044 | $10.74 |
| Q1 2023 | -34,350 | Sold Out | 0 | $0.00 |
| Q4 2022 | +34,350 | New Buy | 34,350 | $0.01 |
| Q3 2021 | -33,481 | Sold Out | 0 | $0.00 |
| Q2 2021 | +33,481 | New Buy | 33,481 | $22.85 |
| Q4 2016 | -20,600 | Sold Out | 0 | $0.00 |
| Q3 2016 | +20,600 | New Buy | 20,600 | $3.64 |
Paul Tudor Jones's Anavex Life Sciences Investment FAQs
Paul Tudor Jones first purchased Anavex Life Sciences Corp. (AVXL) in Q3 2016, acquiring 20,600 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Anavex Life Sciences Corp. (AVXL) for 9 quarters since Q3 2016.
Paul Tudor Jones's largest addition to Anavex Life Sciences Corp. (AVXL) was in Q4 2024, adding 46,044 shares worth $494,513.
According to the latest 13F filing for Q1 2026, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 42,708 shares of Anavex Life Sciences Corp. (AVXL), valued at approximately $131,114.
As of the Q1 2026 filing, Anavex Life Sciences Corp. (AVXL) represents approximately 0.00% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings.
Paul Tudor Jones's peak holding in Anavex Life Sciences Corp. (AVXL) was 46,044 shares, as reported at the end of Q4 2024.